BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9592337)

  • 1. [The role of human leukocyte antigen in susceptibility and clinical manifestations of sarcoidosis].
    Xu Z; Zhu X; Zhao Y
    Zhonghua Nei Ke Za Zhi; 1996 Nov; 35(11):730-3. PubMed ID: 9592337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of human leukocyte antigen in susceptibility and clinical manifestations of sarcoidosis.
    Xu Z; Zhao Y; Zhu X; Qiu C; Luo W; Zhu Y
    Chin Med J (Engl); 1996 Jul; 109(7):515-8. PubMed ID: 9206096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polymorphism of histocompatibility class II antigens coded with the DRB gene in in familial sarcoidosis in Poland].
    Goljan A; Puścińska E; Sankowska M; Zieliński J
    Pneumonol Alergol Pol; 2000; 68(11-12):533-44. PubMed ID: 11320564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of susceptibility genes in sarcoidosis].
    Ishihara M; Ohno S; Ishida T; Kagiya M; Ando H; Inoko H
    Nippon Ganka Gakkai Zasshi; 1994 Jan; 98(1):80-5. PubMed ID: 8109450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA serological and class II genotyping in sarcoidosis patients in Japan.
    Ishihara M; Ishida T; Inoko H; Ando H; Naruse T; Nose Y; Ohno S
    Jpn J Ophthalmol; 1996; 40(1):86-94. PubMed ID: 8739505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries.
    Martinetti M; Tinelli C; Kolek V; Cuccia M; Salvaneschi L; Pasturenzi L; Semenzato G; Cipriani A; Bartova A; Luisetti M
    Am J Respir Crit Care Med; 1995 Aug; 152(2):557-64. PubMed ID: 7633707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of HLA-DR antigens in Japanese patients with sarcoidosis.
    Kunikane H; Abe S; Tsuneta Y; Nakayama T; Tajima Y; Misonou J; Wakisaka A; Aizawa M; Kawakami Y
    Am Rev Respir Dis; 1987 Mar; 135(3):688-91. PubMed ID: 3826893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR-RFLP.
    Ishihara M; Inoko H; Suzuki K; Ono H; Hiraga Y; Ando H; Naruse T; Ishida T; Ohno S
    Jpn J Ophthalmol; 1996; 40(4):540-3. PubMed ID: 9130059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic influences on sarcoidosis.
    Ishihara M; Ohno S
    Eye (Lond); 1997; 11 ( Pt 2)():155-61. PubMed ID: 9349405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II (DR, DQ, DP) in patients with sarcoidosis: evidence of an increased frequency of DRw6.
    Odum N; Milman N; Jakobsen BK; Georgsen J; Svejgaard A
    Exp Clin Immunogenet; 1991; 8(4):227-32. PubMed ID: 1817566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens associated with sarcoidosis.
    Lenhart K; Kolek V; Bártova A
    Dis Markers; 1990; 8(1):23-9. PubMed ID: 2311346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
    Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A probe for evaluating the role of HLA class II antigens coded with the DRB gene in etiopathogenesis of familial sarcoidosis in Poland using the K-nearest neighbor experimental statistical method].
    Goljan A; Puścińska E; Sankowska M; Jóźwik A; Zieliński J
    Pneumonol Alergol Pol; 2000; 68(11-12):545-56. PubMed ID: 11320565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis.
    Kunikane H; Abe S; Yamaguchi E; Aparicio JM; Wakisaka A; Yoshiki T; Kawakami Y
    Thorax; 1994 Jun; 49(6):573-6. PubMed ID: 7912453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic difference in HLA-DR phenotypes between coeliac disease and transitory gluten intolerance.
    Meuli R; Pichler WJ; Gaze H; Lentze MJ
    Arch Dis Child; 1995 Jan; 72(1):29-32. PubMed ID: 7717732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
    Kratz LE; Boughman JA; Needleman BW
    Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in northern Italy.
    Ferraccioli G; Savi M
    J Rheumatol; 1988 Jan; 15(1):51-3. PubMed ID: 3258384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.
    Ramezani A; Hasanjani Roshan MR; Kalantar E; Eslamifar A; Banifazl M; Taeb J; Aghakhani A; Gachkar L; Velayati AA
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1716-21. PubMed ID: 18761557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: role of genetics in susceptibility and outcome of sarcoidosis.
    Grunewald J
    Semin Respir Crit Care Med; 2010 Aug; 31(4):380-9. PubMed ID: 20665388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.